Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
The Ensign Group, Inc. announced its first quarter 2026 results showing significant growth in earnings and revenue, with GAAP diluted EPS up 21.9% to $1.67 and adjusted EPS rising 21.7% to $1.85. The firm reported increased occupancy and skilled nursing revenue rates, expanded its healthcare operations portfolio with key acquisitions, and raised it…
Westwood Holdings Group, Inc. reported its Q1 2026 results showing growth in assets under management to $18.3 billion, driven by strong performance in Energy and Real Assets strategies and growth in ETFs and private energy secondaries funds. Quarterly revenues totaled $25.0 million, slightly down from the previous quarter but above last year's firs…
Resmed, a leader in health technology focused on sleep and breathing, announced the retirement of longtime CFO Brett Sandercock effective May 4, 2026. Aaron Bloomer, formerly CFO at Exact Sciences, will succeed him. The company reiterated its fiscal 2026 financial outlook, signaling stable operational expectations moving forward.
SI-BONE, Inc., a Nasdaq-listed medical device company specializing in procedural solutions for compromised bone, announced its participation in the 2026 BofA Securities Healthcare Conference with a scheduled fireside chat. The event offers management a platform to discuss company developments and engage with investors.
A recent regulatory filing with the Securities and Exchange Commission has revealed that Michelle R. Cassabaum, a director at Ames National Corp (NASDAQ: ATLO), has increased her position in the company through a purchase of common stock. The transaction, which occurred on April 30, 2026, involved the acquisition of 84 shares at a price point of $2…
Royal Caribbean (RCL) looks set to keep recovering its pricing power despite near-term oil volatility. The company trades at a reasonable P/E (~16x) with strong ROE (42.5%) and positive free cash flow. We present a mid-term trade: entry $265.00, target $320.00, stop $242.00, horizon mid term (45 trading days).
Jonathan Anderman, the General Counsel for Compass Therapeutics, Inc. (NASDAQ:CMPX), has expanded his holdings in the company through a direct purchase of common stock. The transaction, which took place on April 29, 2026, involved an acquisition of 25,000 shares via the open market at a price per share of $1.89. This move brings the total value of …
Rivian said it will receive up to $4.5 billion from the U.S. Department of Energy to build its Georgia manufacturing plant, about $2 billion less than the previously approved $6.6 billion. The company said it will draw the funds earlier than planned in 2027, expand initial annual capacity at the plant to 300,000 units from 200,000, and keep its ful…
Aligos Therapeutics, a clinical stage biotechnology company specializing in therapies for liver and viral diseases, announced it will report its first quarter 2026 financial results on May 7, 2026, after the U.S. markets close. The company focuses on developing treatments for chronic hepatitis B, metabolic-associated steatohepatitis, obesity, and c…
Cue Biopharma announces the appointment of Shao-Lee Lin, M.D., Ph.D., as CEO, President, and Board Director to steer the company’s transition into a clinical-stage biopharmaceutical company. Dr. Lin brings over 25 years of experience leading biotech firms and advancing drug candidates. The company is progressing its lead autoimmune candidate, CUE-4…
Syntec Optics Holdings, Inc. successfully closed a $20 million underwritten public offering of 2,857,142 common shares priced at $7.00 each. The company plans to use the proceeds to acquire or invest in complementary businesses, technologies, products or assets, as well as for working capital, capital expenditures, and to optimize its capital struc…
Provident Financial Services, Inc. announced a quarterly cash dividend of $0.24 per common share payable on May 29, 2026, to shareholders of record as of May 15, 2026. Provident Financial Services is the holding company for Provident Bank, serving communities in New Jersey, Pennsylvania, and New York with banking, wealth management, and insurance s…
Cibus, Inc., an agricultural technology company specializing in gene editing plant traits, will report its first quarter 2026 financial results on May 14, 2026, followed by a conference call. The company focuses on developing traits to improve crop productivity, yield, and sustainability, licensing these traits to seed companies.
PEDEVCO Corp. (NYSE American: PED), an energy company specializing in strategic oil and gas assets mainly in the Rocky Mountain and Permian Basins, announced its first quarter 2026 financial results will be released prior to a conference call on May 14, 2026. The company recently completed a merger in October 2025, significantly expanding its asset…
Matrix Service Company, a leading engineering and construction firm for energy and industrial markets, announced that CFO Kevin Cavanah will leave the company after the filing of the fiscal 2026 Annual Report. The company has engaged an executive search firm to find a replacement. The departure is not due to disagreements on accounting or operation…
Trupanion, Inc., a leading pet medical insurance provider, reported its first quarter 2026 results showing 12% total revenue growth year-over-year to $384 million, driven largely by a 16% increase in subscription revenue. The company achieved net income of $4.9 million, a significant improvement from a net loss in Q1 2025, supported by strong adjus…
Larimar Therapeutics announced the publication of research demonstrating that treatment with their lead drug candidate, nomlabofusp, increases frataxin (FXN) levels in tissues relevant to Friedreich’s Ataxia (FA). These frataxin increases correlate between critical tissues and accessible peripheral tissues such as skin and buccal cells, supporting …
Swarmer, Inc, a Nasdaq-listed drone autonomy software company, announced its Q1 2026 earnings release and conference call scheduled for May 13, 2026. The company supports drone operations in Ukraine and has completed over 100,000 combat missions. Swarmer provides autonomous swarm coordination and AI-powered control software primarily licensed to dr…
Resmed Inc. announced its Q3 fiscal 2026 results with revenue up 11% to $1.43 billion and non-GAAP diluted EPS increasing 21% to $2.86. The company achieved 290 basis points gross margin improvement and 18% increase in non-GAAP operating income. Growth was driven by higher sales of sleep devices, masks, and software, with expansion in U.S., Canada,…
Ten-League International Holdings Limited, a Singapore-based turnkey project solutions provider, reported fiscal year 2025 financial results with 30.2% revenue growth to S$76.2 million (US$59.2 million) and a 196.5% increase in net income to S$5.6 million (US$4.3 million). The company's gross profit margin improved due to a favorable product mix an…
Terrestrial Energy Inc., a Nasdaq-listed developer of Generation IV small modular nuclear reactors, announced it will release its first quarter 2026 earnings before market open on May 14, 2026, followed by a conference call. The company is advancing its proprietary Integral Molten Salt Reactor technology targeting commercial deployment in the early…
Exponent, Inc. reported strong first quarter fiscal 2026 results with a 14% increase in total revenues to $166.3 million and a rise in net income to $29.6 million. Growth was fueled by both proactive and reactive engagements, particularly in AI-enabled consumer electronics, utility risk management, and dispute-related services. The company increase…
Exponent, Inc. has declared a quarterly dividend of $0.31 per share for Q2 2026 and increased its stock repurchase authorization by $50 million. The company cites strong profitability and a robust balance sheet as the basis for its continued commitment to returning capital to shareholders through dividends and share buybacks.
Fidus Investment Corporation will report its first quarter 2026 financial results on May 7, 2026 after market close and will hold a conference call on May 8 to discuss results. The company provides debt and equity financing to U.S. lower middle-market companies and aims for attractive risk-adjusted returns through its investment activities.
Century Therapeutics announced an oral presentation of their CNTY-813 iPSC-derived islet cell replacement therapy at the American Diabetes Association's 86th Scientific Sessions. The company highlights progress in developing a scalable, off-the-shelf cell therapy platform engineered to reduce reliance on immunosuppressive drugs for type 1 diabetes …
